[go: up one dir, main page]

HK1060734A - 肿瘤坏死因子α抑制剂 - Google Patents

肿瘤坏死因子α抑制剂 Download PDF

Info

Publication number
HK1060734A
HK1060734A HK04103730.5A HK04103730A HK1060734A HK 1060734 A HK1060734 A HK 1060734A HK 04103730 A HK04103730 A HK 04103730A HK 1060734 A HK1060734 A HK 1060734A
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
alkyl
substituted
amino
carbamoyl
Prior art date
Application number
HK04103730.5A
Other languages
English (en)
Inventor
W. Muller George
Shire Mary
Original Assignee
Celgene Corporation
George Muller
Shire Mary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation, George Muller, Shire Mary filed Critical Celgene Corporation
Publication of HK1060734A publication Critical patent/HK1060734A/zh

Links

HK04103730.5A 1995-08-29 2004-05-25 肿瘤坏死因子α抑制剂 HK1060734A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US520710 1995-08-29

Publications (1)

Publication Number Publication Date
HK1060734A true HK1060734A (zh) 2004-08-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP0851857B1 (en) Inhibitors of tumor necrosis factor alpha
US5658940A (en) Succinimide and maleimide cytokine inhibitors
US5728844A (en) Immunotherapeutic agents
EP0800505B1 (en) Novel immunotherapeutic aryl amides
US6518281B2 (en) Immunotherapeutic agents
EP0797437B1 (en) IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNFalpha
NZ536287A (en) Use of succinimide and maleimide cytokine inhibitors to reduce the levels of TNF in a mammal
HK1060734A (zh) 肿瘤坏死因子α抑制剂
HK1022692B (zh) 肿瘤坏死因子a抑制剂
HK1017885B (zh) 琥珀酰亚胺和马来酰亚胺细胞因子抑制剂